1 September 2016 in eneuro
SRSandhya Krishnan Radhakrishnan
Sandhya Krishnan Radhakrishnan
+1
Clozapine N-oxide (CNO) is a ligand for a powerful chemogenetic system that can selectively inhibit or activate neurons; the so-called Designer Receptors Exclusively Activated by Designer Drugs (DREADD) system. This system consists of synthetic G-protein-coupled receptors, which are not believed to be activated by any endogenous ligand, but are activated by the otherwise inert CNO. However, it has previously been shown that the administration of CNO in humans and rats leads to detectable levels of the bioactive compounds clozapine andN-desmethylclozapine (N-Des). As a follow-up, experiments were conducted to investigate the effects of CNO in male Long–Evans rats. It was found that 1 mg/kg CNO reduced the acoustic startle reflex but had no effect on prepulse inhibition (PPI; a measure of sensorimotor gating). CNO (2 and 5 mg/kg) had no effect on the disruption to PPI induced by the NMDA antagonist phencyclidine or the muscarinic antagonist scopolamine. In locomotor studies, CNO alone (at 1, 2, and 5 mg/kg) had no effect on spontaneous locomotion, but 5 mg/kg CNO pretreatment significantly attenuatedd-amphetamine-induced hyperlocomotion. In line with the behavioral results, fast-scan cyclic voltammetry found that 5 mg/kg CNO significantly attenuated thed-amphetamine-induced increase in evoked dopamine. However, the effects seen after CNO administration cannot be definitively ascribed to CNO because biologically relevant levels of clozapine andN-Des were found in plasma after CNO injection. Our results show that CNO has multiple dose-dependent effectsin vivoand is converted to clozapine andN-Des emphasizing the need for a CNO-only DREADD-free control group when designing DREADD-based experiments.
4 July 2014 in European Journal of Neuroscience
11 September 2014 in European Journal of Neuroscience
8 November 2005 in The FEBS Journal
11 January 2021 in European Journal of Neuroscience
2 November 2021 in European Journal of Neuroscience
DMDuncan Archibald Allan MacLaren
Duncan Archibald Allan MacLaren
MLMartin Peter Konrad Leigh
Martin Peter Konrad Leigh